TTOO Return on Sales vs Current Ratio Analysis

TTOO Stock  USD 3.05  0.19  6.64%   
Trend analysis of T2 Biosystms balance sheet accounts such as Other Liabilities of 5.9 M, Property Plant And Equipment Net of 9.8 M, Net Debt of 59 M or Accounts Payable of 1.6 M provides information on T2 Biosystms' total assets, liabilities, and equity, which is the actual value of T2 Biosystms to its prevalent stockholders. By breaking down trends over time using T2 Biosystms balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in T2 Biosystms. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.

About TTOO Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of T2 Biosystms at a specified time, usually calculated after every quarter, six months, or one year. T2 Biosystms Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of T2 Biosystms and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which TTOO currently owns. An asset can also be divided into two categories, current and non-current.

T2 Biosystms Balance Sheet Chart

T2 Biosystms Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how T2 Biosystms uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, T2 Biosystms' Common Stock Total Equity is very stable compared to the past year. As of the 28th of March 2024, Liabilities And Stockholders Equity is likely to grow to about 62 M, while Short and Long Term Debt Total is likely to drop about 40.9 M.

Total Assets

Total assets refers to the total amount of T2 Biosystms assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in T2 Biosystms books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on T2 Biosystms balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of T2 Biosystms are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from T2 Biosystms' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into T2 Biosystms current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in T2 Biosystms. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.As of the 28th of March 2024, Selling General Administrative is likely to drop to about 26 M. In addition to that, Issuance Of Capital Stock is likely to drop to about 45 M
 2021 2022 2023 2024 (projected)
Interest Expense6.6M6.1M5.7M5.0M
Depreciation And Amortization318K39K35.1K33.3K

T2 Biosystms fundamental ratios Correlations

0.450.260.110.880.160.55-0.24-0.240.10.750.550.370.170.40.840.240.050.17-0.450.330.35-0.60.550.90.01
0.450.810.370.340.650.950.63-0.920.54-0.040.89-0.30.620.870.050.820.040.37-0.380.90.99-0.260.950.20.21
0.260.810.780.240.270.680.54-0.780.7-0.070.58-0.230.330.7-0.040.540.460.56-0.650.630.8-0.280.680.080.64
0.110.370.780.18-0.220.230.2-0.340.380.060.120.05-0.150.220.020.050.810.57-0.780.090.35-0.270.230.070.96
0.880.340.240.18-0.150.4-0.42-0.050.010.830.370.51-0.040.30.89-0.010.290.18-0.650.180.23-0.80.40.920.16
0.160.650.27-0.22-0.150.650.78-0.790.31-0.440.7-0.590.860.57-0.330.95-0.63-0.030.240.790.690.110.65-0.21-0.41
0.550.950.680.230.40.650.54-0.830.520.050.95-0.140.550.810.160.77-0.020.26-0.290.820.92-0.241.00.30.06
-0.240.630.540.2-0.420.780.54-0.830.54-0.780.56-0.650.640.54-0.70.85-0.220.260.050.690.70.220.54-0.580.02
-0.24-0.92-0.78-0.34-0.05-0.79-0.83-0.83-0.610.33-0.80.54-0.73-0.820.24-0.930.1-0.370.23-0.9-0.950.06-0.830.08-0.15
0.10.540.70.380.010.310.520.54-0.61-0.290.51-0.170.270.61-0.190.490.130.59-0.20.590.560.040.52-0.070.23
0.75-0.04-0.070.060.83-0.440.05-0.780.33-0.29-0.040.56-0.26-0.030.96-0.390.29-0.1-0.42-0.21-0.15-0.560.050.920.11
0.550.890.580.120.370.70.950.56-0.80.51-0.04-0.030.480.760.140.79-0.160.38-0.180.830.87-0.170.950.28-0.03
0.37-0.3-0.230.050.51-0.59-0.14-0.650.54-0.170.56-0.03-0.77-0.330.64-0.580.350.22-0.2-0.44-0.37-0.21-0.140.590.18
0.170.620.33-0.15-0.040.860.550.64-0.730.27-0.260.48-0.770.54-0.250.86-0.54-0.230.040.740.63-0.140.55-0.14-0.36
0.40.870.70.220.30.570.810.54-0.820.61-0.030.76-0.330.540.050.730.030.5-0.270.860.88-0.210.810.20.07
0.840.05-0.040.020.89-0.330.16-0.70.24-0.190.960.140.64-0.250.05-0.280.20.04-0.38-0.08-0.05-0.540.160.990.06
0.240.820.540.05-0.010.950.770.85-0.930.49-0.390.79-0.580.860.73-0.28-0.410.18-0.030.890.84-0.040.77-0.13-0.17
0.050.040.460.810.29-0.63-0.02-0.220.10.130.29-0.160.35-0.540.030.2-0.410.44-0.75-0.290.0-0.37-0.020.180.87
0.170.370.560.570.18-0.030.260.26-0.370.59-0.10.380.22-0.230.50.040.180.44-0.380.360.39-0.030.260.140.56
-0.45-0.38-0.65-0.78-0.650.24-0.290.050.23-0.2-0.42-0.18-0.20.04-0.27-0.38-0.03-0.75-0.38-0.1-0.310.81-0.29-0.42-0.72
0.330.90.630.090.180.790.820.69-0.90.59-0.210.83-0.440.740.86-0.080.89-0.290.36-0.10.92-0.090.820.08-0.07
0.350.990.80.350.230.690.920.7-0.950.56-0.150.87-0.370.630.88-0.050.840.00.39-0.310.92-0.160.920.10.19
-0.6-0.26-0.28-0.27-0.80.11-0.240.220.060.04-0.56-0.17-0.21-0.14-0.21-0.54-0.04-0.37-0.030.81-0.09-0.16-0.24-0.55-0.2
0.550.950.680.230.40.651.00.54-0.830.520.050.95-0.140.550.810.160.77-0.020.26-0.290.820.92-0.240.30.06
0.90.20.080.070.92-0.210.3-0.580.08-0.070.920.280.59-0.140.20.99-0.130.180.14-0.420.080.1-0.550.30.08
0.010.210.640.960.16-0.410.060.02-0.150.230.11-0.030.18-0.360.070.06-0.170.870.56-0.72-0.070.19-0.20.060.08
Click cells to compare fundamentals

T2 Biosystms Account Relationship Matchups

T2 Biosystms fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets28.5M79.1M60.5M34.4M39.5M62.0M
Short Long Term Debt Total44.8M55.8M57.1M59.2M68.1M40.9M
Other Current Liab13.6M6.4M7.2M7.7M8.8M6.6M
Total Current Liabilities60.6M9.8M11.7M10.5M12.1M23.0M
Total Stockholder Equity(34.0M)8.7M(12.9M)(40.0M)(46.0M)(43.7M)
Other Liab46K4.8M4.6M4.9M5.6M5.9M
Property Plant And Equipment Net9.2M14.8M14.4M13.3M15.3M9.8M
Net Debt33.7M39.0M34.9M48.9M56.2M59.0M
Retained Earnings(376.2M)(423.0M)(472.2M)(534.5M)(481.1M)(457.0M)
Accounts Payable3.8M2.1M2.8M1.3M1.5M1.6M
Cash11.0M16.8M22.2M10.3M9.3M8.8M
Non Current Assets Total9.6M25.5M16.1M15.0M17.2M11.7M
Cash And Short Term Investments11.0M42.2M32.2M10.3M9.3M8.8M
Common Stock Total Equity36K44K51K147K169.1K177.5K
Common Stock Shares Outstanding455.1K24.3K31.8K51.0K58.7K55.7K
Liabilities And Stockholders Equity28.5M79.1M60.5M34.4M39.5M62.0M
Non Current Liabilities Total1.9M60.6M61.8M63.9M57.5M34.1M
Other Current Assets1.4M2.7M3.1M2.6M3.0M1.5M
Other Stockholder Equity342.1M431.5M459.2M494.6M568.7M288.0M
Total Liab62.5M70.4M73.4M74.4M66.9M50.8M
Property Plant And Equipment Gross9.2M14.8M14.4M13.3M15.3M9.8M
Total Current Assets18.9M53.6M44.4M19.4M17.5M16.6M
Accumulated Other Comprehensive Income(11.3M)(13.2M)9K(4K)(3.6K)(3.8K)
Short Term Debt42.9M1.2M1.2M1.4M1.6M1.5M
Common Stock49K147K166K8K9.2K8.7K
Property Plant Equipment5.8M14.8M14.4M13.3M15.3M9.5M
Net Tangible Assets(32.1M)8.7M(12.9M)(40.0M)(36.0M)(34.2M)
Current Deferred Revenue285K230K518K172K154.8K147.1K
Net Receivables2.8M5.1M5.1M2.2M2.5M2.2M
Retained Earnings Total Equity(266.1M)(317.2M)(376.2M)(423.0M)(380.7M)(399.7M)
Capital Surpluse267.4M328.5M342.1M431.5M496.3M308.8M
Inventory3.6M3.6M3.9M4.3M5.0M2.6M
Capital Lease Obligations3.9M10.5M9.4M9.6M11.0M5.7M
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards T2 Biosystms in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, T2 Biosystms' short interest history, or implied volatility extrapolated from T2 Biosystms options trading.

Currently Active Assets on Macroaxis

When determining whether T2 Biosystms offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of T2 Biosystms' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of T2 Biosystms Stock. Outlined below are crucial reports that will aid in making a well-informed decision on T2 Biosystms Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in T2 Biosystms. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for TTOO Stock analysis

When running T2 Biosystms' price analysis, check to measure T2 Biosystms' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy T2 Biosystms is operating at the current time. Most of T2 Biosystms' value examination focuses on studying past and present price action to predict the probability of T2 Biosystms' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move T2 Biosystms' price. Additionally, you may evaluate how the addition of T2 Biosystms to your portfolios can decrease your overall portfolio volatility.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Is T2 Biosystms' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of T2 Biosystms. If investors know TTOO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about T2 Biosystms listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(35.62)
Revenue Per Share
7.933
Quarterly Revenue Growth
(0.60)
Return On Assets
(0.68)
Return On Equity
(6.22)
The market value of T2 Biosystms is measured differently than its book value, which is the value of TTOO that is recorded on the company's balance sheet. Investors also form their own opinion of T2 Biosystms' value that differs from its market value or its book value, called intrinsic value, which is T2 Biosystms' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because T2 Biosystms' market value can be influenced by many factors that don't directly affect T2 Biosystms' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between T2 Biosystms' value and its price as these two are different measures arrived at by different means. Investors typically determine if T2 Biosystms is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, T2 Biosystms' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.